Baldwin Wealth Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50
Closed -$1.7K 987
2024
Q3
$1.7K Hold
50
﹤0.01% 967
2024
Q2
$1.08K Hold
50
﹤0.01% 715
2024
Q1
$1.11K Hold
50
﹤0.01% 657
2023
Q4
$1.38K Hold
50
﹤0.01% 677
2023
Q3
$1.12K Hold
50
﹤0.01% 701
2023
Q2
$1.27K Hold
50
﹤0.01% 712
2023
Q1
$1.11K Hold
50
﹤0.01% 748
2022
Q4
$1.19K Buy
+50
New +$1.16K ﹤0.01% 731

Other funds holding VCYT

Baldwin Wealth Partners's VCYT Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 50 shares — an estimated $1.7K sold.

Baldwin Wealth Partners first reported a position in VCYT in Q4 2022 and held it in 8 quarters. The position peaked at $1.7K in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 50 Veracyte shares in Q4 2024, an estimated $1.7K.
  • Baldwin Wealth Partners first reported a position in Veracyte in Q4 2022 and held it in 8 quarters.
  • Baldwin Wealth Partners's Veracyte position peaked at $1.7K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.